← Eichor
Study identifier: NCT07436039 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Color Change and Desensitization of Molar Incisor Hypomineralization-Affected Enamel Using Biomimetic Nano-Hydroxyapatite Toothpaste

Condition: Molar-Incisor Hypomineralization (MIH)  ·  Sponsor: King Abdulaziz University

PhaseNA
Planned participants60
Who can joinAll sexes, 6 Years to 12 Years
Healthy volunteersNo

About this study

This clinical trial aims to evaluate if nano-hydroxyapatite (Nano-HA) toothpaste effectively treats children with Molar-Incisor Hypomineralization (MIH). It will also assess the safety of Nano-HA toothpaste. The main questions are: * Does Nano-HA toothpaste reduce caries incidence, improve tooth aesthetics, and decrease hypersensitivity? * How does Nano-HA compare to fluoridated toothpaste in terms of outcomes? Participants will: * Use Nano-HA or fluoridated toothpaste daily for 12 months. * Visit the clinic for checkups and evaluations every 1 to 3 months. * Record symptoms, brushing compliance, and sensitivity. The study will compare Nano-HA toothpaste to fluoridated toothpaste to determine its efficacy in managing MIH .

This description comes directly from the study's public registry record.

Talk to the study team

sabbagh  ·  +966 50 566 8481  ·  hjsabbagh@gmail.com

Always discuss trial participation with your own doctor first.

Locations (1)

King Abdulaziz University Hospital, Jeddah, Saudi ArabiaJeddah, Saudi ArabiaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07436039